201 related articles for article (PubMed ID: 24285542)
1. S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.
Xu C; Chen H; Wang X; Gao J; Che Y; Li Y; Ding F; Luo A; Zhang S; Liu Z
J Biol Chem; 2014 Jan; 289(2):827-37. PubMed ID: 24285542
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
3. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
[TBL] [Abstract][Full Text] [Related]
4. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.
Fiorio E; Mercanti A; Terrasi M; Micciolo R; Remo A; Auriemma A; Molino A; Parolin V; Di Stefano B; Bonetti F; Giordano A; Cetto GL; Surmacz E
BMC Cancer; 2008 Oct; 8():305. PubMed ID: 18945363
[TBL] [Abstract][Full Text] [Related]
5. [Expression and regulatory mechanism of S100A14 in breast cancer].
Xu CS; Chen HY; Lu CR; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):252-7. PubMed ID: 27087370
[TBL] [Abstract][Full Text] [Related]
6. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Li X; Wang M; Gong T; Lei X; Hu T; Tian M; Ding F; Ma F; Chen H; Liu Z
Theranostics; 2020; 10(13):5687-5703. PubMed ID: 32483412
[No Abstract] [Full Text] [Related]
7. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer.
Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P
Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380
[TBL] [Abstract][Full Text] [Related]
8. Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation.
Chen H; Yuan Y; Zhang C; Luo A; Ding F; Ma J; Yang S; Tian Y; Tong T; Zhan Q; Liu Z
J Biol Chem; 2012 May; 287(21):17109-17119. PubMed ID: 22451655
[TBL] [Abstract][Full Text] [Related]
9. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
10. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE).
Jin Q; Chen H; Luo A; Ding F; Liu Z
PLoS One; 2011 Apr; 6(4):e19375. PubMed ID: 21559403
[TBL] [Abstract][Full Text] [Related]
11. S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.
Ehmsen S; Hansen LT; Bak M; Brasch-Andersen C; Ditzel HJ; Leth-Larsen R
Int J Cancer; 2015 Nov; 137(9):2093-103. PubMed ID: 25912829
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer.
Zhang Q; Zhu M; Cheng W; Xing R; Li W; Zhao M; Xu L; Li E; Luo G; Lu Y
J Cancer Res Clin Oncol; 2015 Apr; 141(4):691-703. PubMed ID: 25266115
[TBL] [Abstract][Full Text] [Related]
13. S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway.
Jiang S; Zhu Y; Chen Z; Huang Z; Liu B; Xu Y; Li Z; Lin Z; Li M
Hum Cell; 2021 Jul; 34(4):1215-1226. PubMed ID: 33890248
[TBL] [Abstract][Full Text] [Related]
14. 12-O-tetradecanoylphorbol-13-acetate promotes breast cancer cell motility by increasing S100A14 level in a Kruppel-like transcription factor 4 (KLF4)-dependent manner.
He H; Li S; Chen H; Li L; Xu C; Ding F; Zhan Y; Ma J; Zhang S; Shi Y; Qu C; Liu Z
J Biol Chem; 2014 Mar; 289(13):9089-99. PubMed ID: 24532790
[TBL] [Abstract][Full Text] [Related]
15. IQGAP1 protein binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistance.
White CD; Li Z; Dillon DA; Sacks DB
J Biol Chem; 2011 Aug; 286(34):29734-47. PubMed ID: 21724847
[TBL] [Abstract][Full Text] [Related]
16. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.
Ceran C; Cokol M; Cingoz S; Tasan I; Ozturk M; Yagci T
BMC Cancer; 2012 Oct; 12():450. PubMed ID: 23033967
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.
Zhao H; Chen D; Wang J; Yin Y; Gao Q; Zhang Y
Int J Clin Exp Pathol; 2014; 7(2):670-6. PubMed ID: 24551288
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.
Caiazza F; Harvey BJ; Thomas W
Mol Endocrinol; 2010 May; 24(5):953-68. PubMed ID: 20211985
[TBL] [Abstract][Full Text] [Related]
20. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
